Abstract
Objective
To compare the onset of action and efficacy of sodium ibuprofen (ibuprofen sodium dihydrate) and ibuprofen acid incorporating poloxamer (ibuprofen/poloxamer) with that of acetaminophen and placebo in patients with post-operative dental pain.
Methods
A double-blind, randomised, placebo-controlled, active comparator, two-centre study assessing the analgesic efficacy of sodium ibuprofen (512 mg, equivalent to 400 mg ibuprofen acid), ibuprofen/poloxamer (containing 400 mg ibuprofen acid and 120 mg poloxamer 407), acetaminophen (1000 mg) and placebo in patients with moderate-to-severe pain after third molar extraction (n = 322). Onset of action was assessed using the two-stopwatch technique, and pain intensity and relief were measured using validated traditional descriptor scales.
Results
Significantly more patients achieved confirmed perceptible pain relief and meaningful pain relief with sodium ibuprofen (96.3%, P < 0.0001) and ibuprofen/poloxamer (90.0%, P = 0.0005) than with acetaminophen (67.5%). The onset of action of both ibuprofen formulations was comparable with that of acetaminophen up to 45 min post-dose; a marked divergence in onset times in favour of the ibuprofen formulations occurred from 45 min onward. Mean values for the area under the pain relief and pain intensity differences curve (0–6 h) were significantly greater for sodium ibuprofen (3.46) and ibuprofen acid (3.49) than for acetaminophen (2.25) (P < 0.001). Other pain relief and pain intensity endpoints favoured both ibuprofen formulations over acetaminophen. Distractibility from pain (6 h) was significantly greater with the ibuprofen formulations than with acetaminophen (P = 0.008 for sodium ibuprofen; P = 0.03 for ibuprofen/poloxamer). In patients receiving ibuprofen, pain interfered less with daily activities (at 1 and 6 h) than in those receiving acetaminophen (P ≤ 0.015). Both ibuprofen formulations had significantly better mean global assessment scores than acetaminophen (P < 0.001). Tolerability profiles of the ibuprofen formulations were comparable with that of acetaminophen.
Conclusions
Compared with acetaminophen, sodium ibuprofen was associated with significantly greater analgesic efficacy, pain relief in a greater proportion of patients and greater patient satisfaction.
Similar content being viewed by others
References
Sweetman SC (ed) (2002) Ibuprofen. In: Martindale: the complete drug reference, 33rd edn. Pharmaceutical Press, London
Mehlisch DR, Sollecito WA, Helfrick JF et al (1990) Multicenter clinical trial of ibuprofen and acetaminophen in the treatment of postoperative dental pain. J Am Dent Assoc 121:257–263
Roy S (1983) A double-blind comparison of propionic acid derivative (ibuprofen) and a fenamate (mefanamic acid) in the treatment of dysmenorrhoea. Obstet Gynecol 61:628–632
Moran M (1991) Double-blind comparison of diclofenac potassium, ibuprofen and placebo in the treatment of ankle sprain. J Int Med Res 19:121–130
Goswick CB (1983) Ibuprofen versus propoxyphene hydrochloride and placebo in acute musculoskeletal trauma. Curr Ther Res Clin Exp 34:685–692
Schachtel BP, Thoden WR (1988) Onset of action of ibuprofen in the treatment of muscle-contraction headache. Headache 28:471–474
Pearce I, Frank GJ, Pearce JMS (1983) Ibuprofen compared with acetaminophen in migraine. Practitioner 227:465–467
Dewland P, Reader S, Berry P (2008) Bioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteers. Eur J Clin Pharmacol (submitted)
Geisslinger G, Menzel S, Wissel K, Brune K (1993) Single dose pharmacokinetics of different formulations of ibuprofen and aspirin. Drug Invest 5:238–242
Schleier P, Prochnau A, Schmidt-Westhausen AM et al (2007) Ibuprofen sodium dihydrate, an ibuprofen formulation with improved absorption characteristics, provides faster and greater pain relief than ibuprofen acid. Int J Clin Pharmacol Ther 45:89–97
Black P, Max MB, Desjardins P et al (2002) A randomized, double-blind, placebo-controlled comparison of the analgesic efficacy, onset of action, and tolerability of ibuprofen arginate and ibuprofen in postoperative dental pain. Clin Ther 24:1072–1089
Desjardins P, Black P, Papageorge M et al (2002) Ibuprofen arginate provides effective relief from postoperative dental pain with a more rapid onset of action than ibuprofen. Eur J Clin Pharmacol 58:387–394
Albert KS, Gernaat CM (1984) Pharmacokinetics of ibuprofen. Am J Med 77:40–46
Davies NM (1998) Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin Pharmacokinet 34:101–114
Cooper SA, Precheur H, Rauch D et al (1984) The analgesic efficacy of ibuprofen compared to acetaminophen with codeine (abstract). Clin Pharmacol Ther 35:232
Mehlisch D, Frakes L (1984) A controlled comparative evaluation of acetaminophen and aspirin in the treatment of post-operative pain. Clin Ther Exerpta Med 7:89–97
Mehlisch D, Markenson J Schnitzer T (1999) The efficacy of nonsteroidal anti-inflammatory drugs for acute pain. Cancer Control 6:5–9
Daniels SE, Desjardins PJ, Talwalker S et al (2002) The analgesic efficacy of valdecoxib vs. oxycodone/acetaminophen after oral surgery. J Am Dental Assoc 133:611–621
Mehlisch DR, Ardia A, Pallotta T (2002) A controlled comparative study of ibuprofen arginate versus conventional ibuprofen in the treatment of postoperative dental pain. J Clin Pharmacol 42:904–911
World Medical Association (1964) Declaration of Helsinki: Ethical principles for medical research involving human patients. Adopted by the 18th WMA General Assembly 1964 and amended by the 29th, 35th, 41st and 48th WMA General Assemblies
European Parliament and Council of 4 April 2001 (2001) Directive 2001/20/EC of the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Communities, Brussels
Mehlisch DR, Jasper RD, Brown P et al (1995) Comparative study of ibuprofen lysine and acetaminophen in patients with postoperative dental pain. Clin Ther 17:852–860
Olson NZ, Otero AM, Marrero I et al (2001) Onset of analgesia for liquigel ibuprofen 400 mg, acetaminophen 1000 mg, ketoprofen 25 mg, and placebo in the treatment of postoperative dental pain. J Clin Pharmacol 41:1238–1247
Sachs C (2005) Oral analgesics for acute nonspecific pain. Am Fam Physician 71:913–918
Doyle G, Furey S, Berlin R et al (1999) Gastrointestinal safety and tolerance of ibuprofen at maximum over-the-counter dose. Aliment Pharmacol Ther 13:897–906
Henry D, Lim LL, Garcia Rodriguez LA et al (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of collaborative met-analysis. Br Med J 312:1563–1566
Henry D, McGettigan P (2003) Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs. Int J Clin Pract 135:43–49
Acknowledgements
The authors would like to acknowledge Franklin S. Bonasso, DDS and R. Dean Jasper, DDS (Central Oral Surgery Group), Barbara Hernandez, MA, CCRC, Michael Goulder (Worldwide Clinical Trials UK Ltd) for statistical support, and Vandana Sahajpal, PhD and Quyen Chu, PhD (Sudler & Hennessey, London) for medical writing support.
Conflict of interest
This study was funded by Reckitt Benckiser Group plc. Stephen Daniels (Premier Research Group, Clinical Research Centers, USA) is the Co-ordinating Investigator. Sandie Reader and Phillip Berry are employees of Reckitt Benckiser Group plc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Daniels, S., Reader, S., Berry, P. et al. Onset of analgesia with sodium ibuprofen, ibuprofen acid incorporating poloxamer and acetaminophen—a single-dose, double-blind, placebo-controlled study in patients with post-operative dental pain. Eur J Clin Pharmacol 65, 343–353 (2009). https://doi.org/10.1007/s00228-009-0614-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-009-0614-y